204
Participants
Start Date
October 1, 2025
Primary Completion Date
December 1, 2026
Study Completion Date
May 1, 2027
Berberine hydrochloride
Subjects will be instructed to take three tablets (300mg) of Berberine hydrochloride two times daily, and visit the hospital every 4 weeks for evaluation of the subjective symptoms and to receive a new supply of medication.
Placebo
Subjects will be instructed to take three tablets (300mg) of placebo two times daily, and visit the hospital every 4 weeks for evaluation of the subjective symptoms and to receive a new supply of medication.
Xijing Hospital of Digestive Diseases
OTHER